相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity
Xiaoli Yan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells
Jun Oura et al.
INTERNATIONAL IMMUNOLOGY (2011)
Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells
Susanne Knudsen et al.
EXPERIMENTAL DERMATOLOGY (2010)
The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells
Leslie Elsner et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Cheng Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Anti-tumor immune responses following neoadjuvant immunotherapy with a recombinant adenovirus expressing HSP72 to rodent tumors
JA Krewet et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
HSP110 induces danger signals upon interaction with antigen presenting cells and mouse mammary carcinoma
MH Manjili et al.
IMMUNOBIOLOGY (2005)
NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation
DP Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70
C Massa et al.
CANCER RESEARCH (2004)
Facets of heat shock protein 70 show immunotherapeutic potential
SM Todryk et al.
IMMUNOLOGY (2003)
Roles of heat-shock proteins in antigen presentation and cross-presentation
ZH Li et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits
T Okada et al.
GENE THERAPY (2001)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri et al.
NATURE MEDICINE (2000)